Log In
Print this Print this

10% high purity intravenous immunoglobulin (IVIG)

  Manage Alerts
Collapse Summary General Information
Company Octapharma AG
Description10% high purity intravenous immunoglobulin
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Protein

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today